Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Decitabine in Untreated Acute Myeloid Leukemia
NCT00492401Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in acute myeloid leukemia (AML), sponsored by National Cancer Institute. Started May 2007; status: completed.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00492401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492401.